Tevogen Bio Holdings (TVGN) Interest Expenses (2023 - 2025)
Tevogen Bio Holdings (TVGN) reported Interest Expenses of $24571.0 for Q1 2025, down 84.23% on a YoY basis from $155786.0 in Q1 2024, and up 55.53% quarter-over-quarter from $15798.0 in Q4 2024.
Tevogen Bio Holdings (TVGN) Interest Expenses (2023 - 2025) Analysis & Trends
Tevogen Bio Holdings has reported Interest Expenses for 3 years, with the latest figure at $24571.0 in Q1 2025.
- For the quarter ending Q1 2025, Interest Expenses fell 84.23% year-over-year to $24571.0; the trailing twelve-month figure through Dec 2025 stood at $24571.0 (down 86.65% YoY), and the FY2024 full-year result was $184037.0, down 84.74% from the prior year.
- Interest Expenses for Q1 2025 stood at $24571.0, up from $15798.0 in the prior quarter.
- The five-year high for Interest Expenses was $317525.0 in Q4 2023, with the low at $12459.0 in Q3 2024.
- Historically, Interest Expenses has averaged $159297.0 across 3 years, with a median of $155786.0 in 2024.
- The largest YoY upside for Interest Expenses was 46.09% in 2024 against a maximum downside of 95.85% in 2024.
- Tevogen Bio Holdings' Interest Expenses stood at $317525.0 in 2023, then sank by 95.02% to $15798.0 in 2024, then jumped by 55.53% to $24571.0 in 2025.
- The last three Interest Expenses figures came in at $24571.0 (Q1 2025), $15798.0 (Q4 2024), and $12459.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -5.58 Mn |
| 10 | Tevogen Bio Holdings | 182.04 Mn | 181.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 24,571.00 |
| Mar 31, 2025 | 24,571.00 |
| Dec 31, 2024 | 15,798.00 |
| Dec 31, 2024 | 15,798.00 |
| Sep 30, 2024 | 12,459.00 |
| Sep 30, 2024 | 12,459.00 |
| Mar 31, 2024 | 155,786.00 |
| Mar 31, 2024 | 155,786.00 |
| Dec 31, 2023 | 317,525.00 |
| Dec 31, 2023 | 317,525.00 |
| Sep 30, 2023 | 299,943.00 |
| Sep 30, 2023 | 299,943.00 |
| Mar 31, 2023 | 288,997.00 |
| Mar 31, 2023 | 288,997.00 |